Russia vs Lithuania vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 97% | 86% |
| 2023 | 97% | 87% |
| 2022 | 97% | 87% |
| 2021 | 97% | 88% |
| 2020 | 97% | 90% |
| 2019 | 98% | 93% |
| 2018 | 98% | 92% |
| 2017 | 98% | 94% |
| 2016 | 98% | 94% |
| 2015 | 98% | 94% |
| 2014 | 98% | 93% |
| 2013 | 98% | 93% |
| 2012 | 98% | 93% |
| 2011 | 98% | 94% |
| 2010 | 98% | 96% |
| 2009 | 98% | 96% |
| 2008 | 99% | 97% |
| 2007 | 99% | 97% |
| 2006 | 99% | 97% |
| 2005 | 99% | 97% |
| 2004 | 98% | 98% |
| 2003 | 98% | 98% |
| 2002 | 98% | 98% |
| 2001 | 97% | 97% |
| 2000 | 97% | 97% |
| 1999 | 97% | 97% |
| 1998 | 94% | 97% |
| 1997 | 91% | 96% |
| 1996 | 88% | 96% |
| 1995 | 85% | 94% |
| 1994 | 81% | 93% |
| 1993 | 88% | 92% |
| 1992 | 83% | 89% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 97% | 89% |
| 2023 | 97% | 90% |
| 2022 | 97% | 90% |
| 2021 | 97% | 90% |
| 2020 | 97% | 91% |
| 2019 | 97% | 92% |
| 2018 | 97% | 92% |
| 2017 | 97% | 94% |
| 2016 | 97% | 94% |
| 2015 | 97% | 93% |
| 2014 | 97% | 93% |
| 2013 | 97% | 93% |
| 2012 | 97% | 93% |
| 2011 | 97% | 92% |
| 2010 | 97% | 95% |
| 2009 | 98% | 98% |
| 2008 | 98% | 96% |
| 2007 | 98% | 95% |
| 2006 | 98% | 94% |
| 2005 | 98% | 94% |
| 2004 | 97% | 94% |
| 2003 | 96% | 94% |
| 2002 | 97% | 95% |
| 2001 | 96% | 95% |
| 2000 | 96% | 94% |
| 1999 | 95% | 93% |
| 1998 | 91% | 93% |
| 1997 | 88% | 90% |
| 1996 | 84% | 91% |
| 1995 | 78% | 90% |
| 1994 | 88% | 83% |
| 1993 | 79% | 83% |
| 1992 | 73% | 78% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 97% | 87% |
| 2023 | 97% | 90% |
| 2022 | 97% | 90% |
| 2021 | 97% | 90% |
| 2020 | 97% | 91% |
| 2019 | 97% | 92% |
| 2018 | 97% | 93% |
| 2017 | 97% | 94% |
| 2016 | 97% | 95% |
| 2015 | 97% | 94% |
| 2014 | 97% | 94% |
| 2013 | 97% | 93% |
| 2012 | 97% | 93% |
| 2011 | 97% | 95% |
| 2010 | 97% | 94% |
| 2009 | 98% | 95% |
| 2008 | 98% | 96% |
| 2007 | 98% | 96% |
| 2006 | 98% | 95% |
| 2005 | 97% | 95% |
| 2004 | 96% | 94% |
| 2003 | 94% | 95% |
| 2002 | 81% | 94% |
| 2001 | 43% | 95% |
| 2000 | - | 98% |
| 1999 | - | 96% |
| 1998 | - | 73% |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 97% of children aged 12–23 months in Russia and 86% in Lithuania: 11 percentage points more in Russia. The third DTP dose reaches 97% in Russia and 89% in Lithuania, 8 points more in Russia. The third hepatitis B dose reaches 97% in Russia and 87% in Lithuania, 10 points more in Russia. In 1992, the first measles dose reached 83% in Russia and 89% in Lithuania, 6 percentage points more in Lithuania.
Russia vs Lithuania: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 97% (2024) | 86% (2024) |
| DTP3 | 97% (2024) | 89% (2024) |
| HepB3 | 97% (2024) | 87% (2024) |
Russia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Lithuania and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Russia and its fourteen neighbors, the latest coverage of the first measles dose is highest in North Korea, at 99%, and lowest in Azerbaijan, at 71%; of Lithuania and its four neighbors, the latest coverage of the first measles dose is highest in Belarus, at 98%, and lowest in Lithuania, at 86%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.